MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 7 | 0.0 |
Animals | 29 | 0.0 |
Base Sequence | 7 | 0.0 |
Cells, Cultured | 9 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Dogs | 2 | 0.0 |
Humans | 41 | 0.0 |
Molecular Sequence Data | 11 | 0.0 |
Protein-Serine-Threonine Kinases/*genetics/*metabolism | 2 | 10.0 |
Research Support, Non-U.S. Gov't | 34 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 22 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Enzyme Activation | 4 | 0.0 |
Glucocorticoids/*pharmacology | 3 | 1.0 |
Kinetics | 2 | 0.0 |
Phosphorylation | 12 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Substrate Specificity | 5 | 0.0 |
Aldosterone/*physiology | 2 | 22.0 |
Proteins/genetics | 2 | 0.0 |
Blotting, Western | 3 | 0.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Female | 11 | 0.0 |
Gene Expression Regulation/*drug effects | 2 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Male | 6 | 0.0 |
Mice | 9 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
*Protein-Serine-Threonine Kinases | 2 | 0.0 |
Rats | 8 | 0.0 |
Rats, Sprague-Dawley | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Time Factors | 3 | 0.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 2 | 0.0 |
COS Cells | 3 | 0.0 |
Cell Division | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 3 | 0.0 |
Hela Cells | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
Transfection | 4 | 0.0 |
*Nuclear Proteins | 28 | 1.0 |
Protein-Serine-Threonine Kinases/*physiology | 4 | 3.0 |
Sodium/metabolism | 6 | 4.0 |
*Ubiquitin-Protein Ligases | 2 | 0.0 |
Cyclic AMP/*physiology | 2 | 2.0 |
Sodium Channels/*physiology | 2 | 20.0 |
Serine/metabolism | 2 | 0.0 |
Transcription Factors/metabolism | 3 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Gene Expression Profiling | 3 | 0.0 |
Protein-Serine-Threonine Kinases/genetics | 2 | 1.0 |
RNA, Messenger/genetics/metabolism | 6 | 0.0 |
Enzyme Activation/drug effects | 3 | 0.0 |
Cell Line | 14 | 0.0 |
Epithelial Cells | 2 | 0.0 |
*Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Mifepristone/pharmacology | 3 | 3.0 |
Dexamethasone/pharmacology | 2 | 0.0 |
Protein-Serine-Threonine Kinases/*genetics | 5 | 1.0 |
Tumor Cells, Cultured | 3 | 0.0 |
*Signal Transduction | 3 | 0.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 2 | 0.0 |
Apoptosis | 2 | 0.0 |
Binding Sites | 2 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Mutation | 3 | 0.0 |
Protein-Serine-Threonine Kinases/genetics/*metabolism | 6 | 2.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Osmotic Pressure | 2 | 3.0 |
Patch-Clamp Techniques | 4 | 1.0 |
Protein-Serine-Threonine Kinases/genetics/metabolism | 2 | 1.0 |
Sodium/*metabolism | 4 | 6.0 |
Xenopus | 2 | 0.0 |
Cell Survival/*physiology | 2 | 3.0 |
Androstadienes/pharmacology | 2 | 0.0 |
Hydrogen Peroxide/pharmacology | 2 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 2 | 0.0 |
Comparative Study | 3 | 0.0 |
Glucocorticoids/pharmacology | 2 | 1.0 |
Insulin-Like Growth Factor I/pharmacology | 3 | 1.0 |
Protein Binding | 3 | 0.0 |
Signal Transduction/*drug effects | 2 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Protein-Serine-Threonine Kinases/chemistry/*genetics/*metabolism | 2 | 13.0 |
Aldosterone/pharmacology/*physiology | 2 | 66.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Xenopus laevis | 5 | 1.0 |
Adult | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
Hormone Antagonists/pharmacology | 2 | 3.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Models, Biological | 2 | 0.0 |
Electric Conductivity | 2 | 1.0 |
Oocytes/physiology | 2 | 1.0 |
